Finding a ‘Common Morality Codex’ for Biotech: A question of substance

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

As the implementation of the Community Patent Convention 1975 draws ever nearer,1 an increasingly pressing need to resolve the issue of morally assessing inventions across such a diverse range of national sensibilities arises. Without some form of "common morality codex",2 the European Patent Office and the new court regime are likely to encounter criticisms every time Art. 53(a) of the European Patent Convention 1973 (EPC)3 is *IIC 639 called into question.4 Although the cases that raise objections under this provision are rare in comparison with daily requirements for amendments under grant, opposition or infringement proceedings, this is no justification for perceiving the provision as being less in need of scrutiny than those utilised more frequently. All applicants under the patent system are entitled to as much certainty and clarity in the legal requirements they are constrained to comply with, as those very requirements demand of them in return.
LanguageEnglish
Pages638-661
Number of pages24
JournalIIC International Review of Intellectual Property and Competition Law
Volume39
Issue number6
Publication statusPublished - 2008
Externally publishedYes

Fingerprint

patent
morality
patent system
applicant
invention
amendment
grant
opposition
criticism
regime
demand
community
time

Cite this

@article{3e29d382037e49d1b295c2db5a8d25e8,
title = "Finding a ‘Common Morality Codex’ for Biotech: A question of substance",
abstract = "As the implementation of the Community Patent Convention 1975 draws ever nearer,1 an increasingly pressing need to resolve the issue of morally assessing inventions across such a diverse range of national sensibilities arises. Without some form of {"}common morality codex{"},2 the European Patent Office and the new court regime are likely to encounter criticisms every time Art. 53(a) of the European Patent Convention 1973 (EPC)3 is *IIC 639 called into question.4 Although the cases that raise objections under this provision are rare in comparison with daily requirements for amendments under grant, opposition or infringement proceedings, this is no justification for perceiving the provision as being less in need of scrutiny than those utilised more frequently. All applicants under the patent system are entitled to as much certainty and clarity in the legal requirements they are constrained to comply with, as those very requirements demand of them in return.",
keywords = "biotechnological inventions, Civil procedure, EC law, European patents, morality, patentability",
author = "Amanda Warren-Jones",
year = "2008",
language = "English",
volume = "39",
pages = "638--661",
journal = "IIC International Review of Intellectual Property and Competition Law",
issn = "0018-9855",
publisher = "Verlag C.H. Beck",
number = "6",

}

TY - JOUR

T1 - Finding a ‘Common Morality Codex’ for Biotech

T2 - IIC International Review of Intellectual Property and Competition Law

AU - Warren-Jones, Amanda

PY - 2008

Y1 - 2008

N2 - As the implementation of the Community Patent Convention 1975 draws ever nearer,1 an increasingly pressing need to resolve the issue of morally assessing inventions across such a diverse range of national sensibilities arises. Without some form of "common morality codex",2 the European Patent Office and the new court regime are likely to encounter criticisms every time Art. 53(a) of the European Patent Convention 1973 (EPC)3 is *IIC 639 called into question.4 Although the cases that raise objections under this provision are rare in comparison with daily requirements for amendments under grant, opposition or infringement proceedings, this is no justification for perceiving the provision as being less in need of scrutiny than those utilised more frequently. All applicants under the patent system are entitled to as much certainty and clarity in the legal requirements they are constrained to comply with, as those very requirements demand of them in return.

AB - As the implementation of the Community Patent Convention 1975 draws ever nearer,1 an increasingly pressing need to resolve the issue of morally assessing inventions across such a diverse range of national sensibilities arises. Without some form of "common morality codex",2 the European Patent Office and the new court regime are likely to encounter criticisms every time Art. 53(a) of the European Patent Convention 1973 (EPC)3 is *IIC 639 called into question.4 Although the cases that raise objections under this provision are rare in comparison with daily requirements for amendments under grant, opposition or infringement proceedings, this is no justification for perceiving the provision as being less in need of scrutiny than those utilised more frequently. All applicants under the patent system are entitled to as much certainty and clarity in the legal requirements they are constrained to comply with, as those very requirements demand of them in return.

KW - biotechnological inventions

KW - Civil procedure

KW - EC law

KW - European patents

KW - morality

KW - patentability

UR - https://login.westlaw.co.uk/maf/wluk/app/document?&srguid=i0ad832f100000169000a25abc61408ba&docguid=IFC8D1C30DE0211DDA457A252A2855589&hitguid=IFC8D1C30DE0211DDA457A252A2855589&rank=3&spos=3&epos=3&td=13&crumb-action=append&context=31&resolvein=true

UR - https://link.springer.com/journal/volumesAndIssues/40319

M3 - Article

VL - 39

SP - 638

EP - 661

JO - IIC International Review of Intellectual Property and Competition Law

JF - IIC International Review of Intellectual Property and Competition Law

SN - 0018-9855

IS - 6

ER -